Member Info for PM2022

That is down to market perception not always correct. 95% thought 201 will never happen and that TRX will raise zero.

I always said it would. So when it happens we will see where we go and who was right. Also not just about 201.

I think you agree which is why you are here.

Why would anyone listen to someone that has been twisting facts for three years. You just move from one thing to another when you are proven wrong on every occasion. You clearly said TRX will not raise a penny but now you move to something else.

Drug development is expensive. It costs millions to develop a drug through preclinical stages. The assets and collaborations they have allow world class compounds to move through the preclinical stages with much lower risks. It will also attract huge revenue which is shortly to come. Imagen was generating revenue of millions of pounds and PYC also generate decent revenue and some of the other collaborations provide value by giving compounds the highest chances to progress with the technology they have and that allows us to get a huge preclinical deal which is the end goal.

Almost every company requires funding on AIM. Val only burns 2 million and with lab revenue projections will likely reduce to 1 million over the next 12 months with another 1/2 staff once revenue starts to come through. When 201 gets done we will have more cash than what we are burning.

Great strategy, low risk, low cost and huge potential.

Val will get the funding it needs from the 201 deal plus lab contracts. As stated in the presentation it is expected this year. The company has value at this price both short term and long term. If I am not mistaken REDX did a placing at market value yesterday and if Val had such plans it would have already happened.

I am happy to hold and add where necessary as I think we will gap up or rise fast when news breaks and we should continue to move as more news and rumours are released.

The potential of 40,50,60p is very real compared to a temporary minimal false drop.

Porky is only here because he lost all his money on 4D and is bitter with VAL. He has been making up lies for 3 years.

Another deramper. Check posting history.

I was telling everyone he is not well. What lengths to go to posting on that stock.

He is a danger, what next?

No you keep twisting. You said and made it very clear over the last 2 years TRX could not raise a penny.

What a loser you are Porky.

Well if they partly own the compound or buy it later then they control how much it costs to sell. It would therefore be affordable healthcare if they control pricing or have a say in it. They help pay for the trials later and in return will get sales revenue if it passes the trials. For TRX they have access to the main US markets to raise funds for phase 3 if it passes phase 2 but the fact they have funding in place the potential revenue and milestone payments will be factored into the MC. Just like any other company.

Bearing in mind the value of a phase 2 cancer drug is normally in the region of 200/300 million plus so some of that will reflect in MC.

RObster,

https://www.youtube.com/watch?v=ZOBr5Nmb0Ic

They raise funds for phase 2 so I would say 10/20 million for 201 with additional capital for the other compounds plus payments due to us. I still think it will be much higher due to the time taken and other compounds. The merger will assist further down the line perhaps with phase 3.

So you think they are lying to the NASDAQ and VAL BOD has been fooled. What a clown.

You promised everyone TRX cannot raise a dollar so you should do the honorable thing if they raise millions and leave once you find out.

Reposted:

Porky1981: There is no speculation. This is fact. If you look hard enough you will find the prospectus for the completed funding round. An eye watering $$$ fund raise. It’s standard practice to raise private capital for a private company merging with a listed company under these circumstances.

The investment consortium will release the capital to the new listed entity on completion of the merger. You’re telling folks EUDA are merging with a company that has nothing more than letters of intent… what would be the business case of merging if that were true. TheoremRX have collated an eye watering sum of private capital and portfolio of drugs. The EUDA synergy is more than a Nasdaq listing…. lihat dan anda akan mendapat kekayaan.

If TRX raised less than 20 million i will not post if they raise more than 20 million then you disappear.

No response to anyone. No excuses. See if you really believe it.

Porky if TRX are funded say more than 20 million will you agree to not post again. I will do the same.

Regardless of the merger outcome. No ifs and buts you go.

Yeah phase 2 = 10/20 million. Correct. I understand they have two clinical drugs so perhaps need 20-40 million plus payments. Guessing around 100 million. Main thing trails are funded and they can pay Val.

I am sure TRX will raise around 100 million plus. More than one compound makes sense. You don't release statements to Nasdaq saying they have access to strong funding.

Why don't you go and post on other AIM stocks then. Fact is you lost it all on 4D and it is all personal posting 24/7 for the last 3 years repeating the same like about placing.

You know the deal will be completed and funds will be given. Otherwise it would have been done some time ago.

No logic to your argument.

Jwallows has answered below:

Porky1981: There is no speculation. This is fact. If you look hard enough you will find the prospectus for the completed funding round. An eye watering $$$ fund raise. It’s standard practice to raise private capital for a private company merging with a listed company under these circumstances.

The investment consortium will release the capital to the new listed entity on completion of the merger. You’re telling folks EUDA are merging with a company that has nothing more than letters of intent… what would be the business case of merging if that were true. TheoremRX have collated an eye watering sum of private capital and portfolio of drugs. The EUDA synergy is more than a Nasdaq listing…. lihat dan anda akan mendapat kekayaan.

Then from RNS:

VAL201 remains subject to the Letter of Intent ("LoI") with TheoremRx Inc, and we maintain regular lines of communications with the TheoremRx team to monitor progress on their continuing efforts to secure financing, which will enable the VAL201 sub-license to complete. The sub-license contains provisions for upfront and early-stage milestone payment and will release the immediate payment for work already conducted under the previously announced service agreement as well as a commitment for future service provision.

Not to mention the presentation:

Https://www.valirx.com/news/valirx-qa-session-dr-suzanne-dilly-and-dr-kevin-cox

https://www.brrmedia.co.uk/broadcasts-embed/65142ddf01d979c8a2ec78b2/valirx-qa-session/?popup=true#

Watch the first 10 minutes and make up your min

Porky was telling everyone to buy at 50p before he sold and lost it all on 4D. Now full of jealousy.

Deal news to come soon. One thing is for sure with 201 not priced in we should rocket and multi bag.

Below apparently from Patrick of TRX.

THX merger will complete and release pre agreed funds well before end of Q4 2023. Ain’t no dreaming here 💰🚀📈

Hi PJ,

Yes it was you that gave us feedback. Many thanks and yes I believe it was a large amount. I just never saw the logic of Stella and everyone else lying and progress must have been significant.

We will soon find out.

The RNS and presentation confirms they will.

What will get priced in is the size of the deal which includes potential milestones and royalties. Total deal worth few hundred million but some of that gets priced in at the moment so about 30 million odd at this stage imo.

Just like you were saying 201 will never get done.

Jwallows is right.

1) Information in the article makes it clear TRX has strong access to funding. Must be a significant amount. Not likely to just be a few million after 2.5 years raise.

2) A reliable source who attended AGM also said on here the delay was due to very significant amounts being raised.

3) Funding for a few compounds including 2 clinical drugs would have strong backers.

It just all adds up and makes sense.